Recall Register

Food, drugs, devices › Medical Components, Inc dba MedComp

Device recall: C3 Wave App, v. 2.0.5

FDA enforcement event 81439 · Class II · initiated 1 Oct 2018 · status Terminated · terminated 1 Oct 2020

DeviceVoluntary: Firm initiated1 product recordHarleysville, PA

Medical Components, Inc dba MedComp (Harleysville, PA) initiated this device recall on 1 Oct 2018; FDA lists 1 product record under event 81439, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 92% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 1 Oct 2020. Initiation: voluntary: firm initiated. Medical Components, Inc dba MedComp has 17 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Medical Components, Inc dba MedComp, Harleysville, PA.

Reason for recall

"When the iPad is updated with Apple iOS software version 12, the C3 application malfunctions. Upon launching a new procedure, the ECG waves do not appear on the screen, in surface or internal mode. If the C3 application is not operating properly, the PICC procedure must be completed without using alternate methods to confirm PICC tip placement."

Distribution

"Distributed to accounts in AZ, CA, CO, FL, IL, LA, MA, ME, NC, OH, TN, VA, and WV. Foreign distribution to Canada, Croatia, Czech Republic, Great Britain, Greece, Italy, Netherlands, Slovenia, and…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0222-2020C3 Wave App, v. 2.0.524Class IITerminated6 Nov 2019

Context

92%of 2018 device events are Class II1,074 events that year
1product record in this eventfirm median: 1
17events on this register for the firm

Other enforcement events for Medical Components, Inc dba MedComp

InitiatedProduct (first record)TypeClassRecords
13 Jan 2021Power Injectable CT Port insertion kits - Product Usage: is an implantable access device designed to provide repeated acDeviceClass II1
27 Jul 2020Medcomp 15.SF X 24CM Titan HD CATHETER (CUFF 19CM FROM TIP) Ref: THD155024DeviceClass II1
13 Mar 201914F x 20CM SLX Double Lumen Full Tray Hemodialysis catheter insertion kits, Item No. MC061423 Product Usage: An aid for DeviceClass II3
13 Mar 201914F SLX Double Lumen Full Tray Hemodialysis catheter insertion kits, Item No. MC061422DeviceClass II1
12 Jul 2018Duo-Flow XTP Straight Full Set; Hemodialysis catheter insertion kits, AAC02106 AAC02107 AAC02108DeviceClass II11
23 Feb 2018CATHETER REPAIR KIT, REF AAC52001, UDI 884908001891 Product Usage: The Medcomp Repair Kit is indicated for use in replacDeviceClass II10
22 Nov 20178F Plastic Dignity¿ Low Profile CT Port W/Pre-Attached ChronoFlex¿ Polyurethane CatheterDeviceClass II1
25 May 20176.6F Plastic Dignity¿ Low Profile CT Port W/Attachable ChronoFlex¿ Polyurethane Catheter, Catalog # MRCTI66041, UDI#- 88DeviceClass II1
23 Feb 20179.6F Plastic Dignity Mid-Sized CT Port w/Pre-Attached Silicone Catheter The CT Power Injectable Implantable Infusion PorDeviceClass II1
5 May 2016Tearaway Introducer, Model # VS203, VS303, 510 K # 130687, packaged individually in a pouch, 5 pouches per carton, lot #DeviceClass II1

All 17 events for Medical Components, Inc dba MedComp

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "When the iPad is updated with Apple iOS software version 12, the C3 application malfunctions. Upon launching a new procedure, the ECG waves do not appear on the screen, in surface or internal mode. If the C3 application is not operating properly, the PICC procedure must be completed without using alternate methods to confirm PICC tip placement."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Distributed to accounts in AZ, CA, CO, FL, IL, LA, MA, ME, NC, OH, TN, VA, and WV. Foreign distribution to Canada, Croatia, Czech Republic, Great Britain, Greece, Italy, Netherlands, Slovenia, and…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 1 Oct 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.